Adicet Bio, Inc

Adicet Bio is a clinical-stage biotechnology company focused on developing allogeneic gamma delta T cell therapies. Their mission is to deliver best-in-class treatments for patients battling autoimmune diseases and cancer. Adicet's approach utilizes gamma delta T cells, a unique type of immune cell, which they believe holds superior potential compared to traditional alpha beta T cells for treating both autoimmune diseases and cancer. These cells are engineered with chimeric antigen receptors (CARs) and are designed to be "off-the-shelf," meaning they are readily available and can be administered to patients on demand.

Adicet is currently advancing a robust pipeline of gamma delta T cell therapies, with their lead product candidate, ADI-001, in Phase 1 clinical trials for both autoimmune diseases and cancer. Their pipeline also includes several other gamma delta T cell therapy programs in discovery and preclinical development. The company's innovative approach and commitment to developing novel therapies for challenging diseases has garnered significant attention and investment in the biopharmaceutical industry.

Adicet Bio offers a flexible work environment with generous paid time off, including 17 company holidays with an end-of-year shutdown, vacation, sick time, and paid parental leave. They also provide an educational reimbursement program up to $4,000 per year, as well as access to LinkedIn Learning, to encourage employee growth and development.

Adicet Bio offers a comprehensive benefits package to support employee health, happiness, and professional growth. Employees enjoy competitive financial incentives including base salary, annual bonuses, long-term incentives, an Employee Stock Purchase Plan, and a 401(k) with a company match. To ensure employee well-being, Adicet provides comprehensive health plans, flexible spending accounts, a Health Savings Account, life and disability insurance, and various voluntary insurance programs. Recognizing the importance of work-life balance, Adicet offers generous paid time off, paid parental leave, and an Educational Reimbursement program. Additionally, Adicet provides a state-of-the-art facility with free onsite gym access, abundant parking, electric vehicle charging stations, a free shuttle, catered lunches, and fully stocked breakrooms.

Adicet Bio is a clinical-stage biotechnology company focused on developing allogeneic gamma delta T cell therapies for both autoimmune diseases and cancer. Their mission is to deliver best-in-class therapies that utilize the power of these unique immune cells to effectively treat patients suffering from a variety of diseases. Adicet is advancing a pipeline of "off-the-shelf" gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients.

Adicet Bio promotes a culture that values innovation, collaboration, and a passion for translating cutting-edge science into treatments for patients. The company fosters an environment where teams are empowered to exercise excellence while appreciating each other's contributions. They emphasize a deep commitment to developing new therapies with curative potential and a dedication to delivering best-in-class gamma delta T cell therapies for patients fighting autoimmune diseases and cancer.

Adicet Bio prioritizes diversity, equity, and inclusion across its operations, recognizing that a diverse and inclusive workplace is crucial for fostering innovation and achieving its mission of delivering groundbreaking cell therapies. The company strives to create an environment where all employees feel valued, respected, and empowered to contribute their unique perspectives. Adicet actively promotes equal opportunities for all, ensuring fair treatment and equitable access to resources and advancement opportunities. Its commitment to building a diverse team is reflected in its hiring practices, leadership representation, and employee development programs.